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Abstract
Background: The responsiveness of a health system is considered to be an intrinsic goal of  health systems and 
an essential aspect in performance assessment. Numerous studies have analysed health system responsiveness 
and related concepts, especially across different countries and health systems. However, fewer studies have 
applied the concept for the evaluation of specific healthcare delivery structures and thoroughly analysed its 
determinants within one country. The aims of this study are to assess the level of perceived health system 
responsiveness to patients with chronic diseases in ambulatory care in Germany and to analyse the determinants 
of health system responsiveness as well as its distribution across different population groups.
Methods and Analysis: The target population consists of chronically ill people in Germany, with a focus on 
patients suffering from type 2 diabetes and/or from coronary heart disease (CHD). Data comes from two different 
sources: (i) cross-sectional survey data from a postal survey and (ii) claims data from a German sickness fund. 
Data from both sources will be linked at an individual-level. The postal survey has the purpose of measuring 
perceived health system responsiveness, health related quality of life, experiences with disease management 
programmes (DMPs) and (subjective) socioeconomic background. The claims data consists of information on 
(co)morbidities, service utilization, enrolment within a DMP and sociodemographic characteristics, including 
the type of residential area. 
Discussion: RAC is one of the first projects linking survey data on health system responsiveness at individual 
level with claims data. With this unique database, it will be possible to comprehensively analyse determinants 
of health system responsiveness and its relation to other aspects of health system performance assessment. The 
results of the project will allow German health system decision-makers to assess the performance of nonclinical 
aspects of healthcare delivery and their determinants in two important areas of health policy: in ambulatory and 
chronic disease care. 
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Background
In 2000 the World Health Organisation (WHO) defined 
“responsiveness to citizens’ legitimate expectations” as an 
intrinsic goal of health systems and, thus, as a main aspect in 
the performance assessment of health systems.1 In addition 
to the other dimensions of health systems performance 
assessment – health and fairness in financial contribution –, 
responsiveness refers to the nonclinical aspects of healthcare. 
It can further be subdivided into two major categories, each 
composing four domains: “Respect-for-persons” through 
dignity, confidentiality, autonomy, and communication; and 
“Client-orientation” consisting of social support, prompt 
attention, choice of care provider, and quality of basic 
amenities.1
The concept of health system responsiveness, mainly 
focusing on the comparison of health systems, has been used 
frequently in international studies, such as the Multi-Country 
Survey Study on Health and Responsiveness (MCSS),2 the 
World Health Survey (WHS) 2002,3 the Survey of Health, 
Ageing and Retirement in Europe (SHARE)4 and the Study 
on Global Ageing and Adult Health (SAGE).5 Fewer studies 
applied the responsiveness concept for the evaluation of 
specific healthcare delivery structures or particular subgroups 
of the population and analysed its determinants within one 
country.6-8 Moreover, to our knowledge, data on health system 
responsiveness has not yet been linked to claims data (eg, 
from sickness funds) or other routinely collected medical data 
on individual level, allowing for thorough analysis regarding 
(co)morbidities or the utilization of health services.
This manuscript presents the study design and methodology 
of the project “Exploring health system Responsiveness in 
Ambulatory Care and disease management and its relation to 
other dimensions of health system performance” (RAC). RAC 
is part of the Berlin Centre for Health Economics Research 
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(BerlinHECOR), which has the overarching aim to further 
improve the methods for a comprehensive performance 
assessment of German healthcare.9 In this context, the 
project RAC focuses on two relevant aspects of health 
system assessment: the responsiveness of the health system 
to patients with chronic conditions and in ambulatory care 
settings. To allow for a thorough analysis of both aspects, the 
project follows two different approaches: in one study, general 
practitioners (GPs) and their respective patients will be 
surveyed; in the second, a survey is conducted of chronically 
ill patients in ambulatory care (GP and specialist care) and 
these survey data will subsequently be linked to individual 
level administrative claims data from a German sickness 
fund. The second study is carried out in close collaboration 
with the Scientific Institute of Techniker Krankenkasse for 
Benefit and Efficiency in Health Care (Wissenschaftliches 
Institut der Techniker Krankenkasse für Nutzen und Effizienz 
im Gesundheitswesen, WINEG). The following presentation 
of study design and methodology relates to the second 
approach.
In Germany, health insurance is mandatory for all residents. 
In 2014, 85% of the population was covered under statutory 
health insurance (SHI) scheme (represented by 132 different 
sickness funds) and 11% were covered by substitutive 
private health insurance (PHI). Internationally compared, 
Germany spends many of its resources on health (11.4% of 
Gross Domestic Product [GDP] in 2012) and has low cost-
sharing. Insurants have access to a wide range of services 
and free choice of providers.10 A particular characteristic 
of  the German health system is also the separation between 
the hospital sector, in which around 2000 hospitals still 
concentrate on providing inpatient care, and the ambulatory 
care sector, in which more than 120 000 office-based 
physicians (the majority of them often single-handed) not 
only provide family medicine but also specialist care.10 
This study not only aims to assess the level of health system 
responsiveness to patients with chronic diseases in ambulatory 
care in Germany, but also to scrutinize the determinants 
of health system responsiveness as well as the distribution 
of responsiveness across different population groups. This 
includes analyses on (1) differences between participants 
and nonparticipants of disease management programmes 
(DMPs) for the chronically ill, (2) differences among people 
from different residential areas (eg, rural vs. urban) and (3) 
differences among people with differing levels of service 
utilization (eg, high users vs. low users). Analyses will be 
based on a unique dataset – survey data on health system 
responsiveness linked to individual level administrative 
claims data from a German sickness fund – and will thus add 
important new aspects to the existing literature on health 
system responsiveness. 
Methods/Design
The target population of the study is chronically ill people. 
With the aim of having homogenous patient groups, the 
study is split into 2 substudies both focusing on one specific 
(group of) chronic condition: One substudy focuses on type 2 
diabetes and the other concentrates on coronary heart disease 
(CHD). These conditions were chosen for 3 reasons: (1) the 
high prevalence rates, (2) DMPs exist for both conditions, and 
(3) the respective DMPs are highly utilized.11
The study is based on 2 different data sources: Survey data 
from a postal survey and administrative claims data from 
a German sickness fund (Techniker Krankenkasse, TK). 
We will use the benefits from both sources. To assess the 
perceived health system responsiveness of the chronically 
ill, we will conduct a postal survey. Furthermore, the survey 
data will be used to gain insight into the participants’ health 
related quality of life, their experiences with DMPs and their 
(subjective) socioeconomic background (see Final Instrument 
section). Complementing the survey data, information on 
(co)morbidities, service utilization, enrolment within a DMP 
and/or integrated care programme, and sociodemographic 
characteristics, including the type of living area, will be 
obtained from SHI administrative claims data. The advantage 
of using SHI administrative claims data for this information 
is, among others, the avoidance of recall bias (eg, considering 
service utilization) and the avoidance of an overdemanding 
questionnaire (see SHI Administrative Claims Data section). 
Additionally, we will use the SHI claims data for the 
identification of our sample. For all planned data analyses, 
the data from both sources will be linked at individual level. 
Sample
For each substudy (type 2 diabetes and CHD) we aim for a 
sample size of 2500 persons. Due to the planned linkage 
of survey and claims data, participants are not only asked 
to complete and return the questionnaire but to give their 
written informed consent for data linkage. Because experience 
with this study design is limited (with the linking of the data, 
asking participants to complete the questionnaire and to sign 
the consent form), we took a very conservative estimate of the 
response rate (between 10% to 15%). Hence, the initial sample 
consisted of 26 000 persons in each substudy. Eligible study 
participants were selected according to the following criteria.
All persons were continuously insured at the TK from 1 
January 2012 through 23 October 2013. In both substudies, 2 
groups with 13 000 participants each were generated.
1.	 One group of the insured who were continuously 
enrolled in the respective DMP (type 2 diabetes or 
CHD) from at least 1 January 2012 through 23 October 
2013, and 
2.	 A second group of the insured who suffer from type 2 
diabetes and/or CHD, and fulfill the requirements but 
do not yet participate in one of the respective DMPs.
Participants for both groups were selected randomly from 
the whole TK insured population that fulfilled the inclusion 
criteria. Table 1 depicts the inclusion and exclusion criteria. 
Study participants were selected for one of the substudies (eg, 
type 2 diabetes or CHD) only, ie, persons participating in both 
DMPs or who were eligible for both DMPs were included only 
in one substudy. 
Survey Data 
Instrument Development
On the basis of the WHO responsiveness concept, we 
conducted 4 focus groups with chronically ill people to 
test the concept’s applicability for chronic disease care in 
Germany. The results from the focus groups indicated the 
overall suitability of the WHO responsiveness domains for 
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the assessment of chronic care. Two further domains were 
identified for the measurement of the responsiveness of 
chronic disease care: coordination (coordination of course 
of treatment and among different healthcare providers) and 
trust (trust that treatment/consultation is not influenced by 
any motives other than the patients’ well-being).12 Based on 
these results, and the related WHO questionnaires, which 
have been used within the MCSS and the WHS 2002 to 
assess the responsiveness of health systems, we developed the 
German-language survey questionnaire. 
The developed questionnaire was tested qualitatively applying 
the Three-Step Test-Interview.13 We conducted cognitive 
interviews with 6 participants, all with chronic conditions and, 
thus, reflecting the target group of the postal survey. Overall, 
the respondents rated the questionnaire as clear and easy to 
understand and only slight modifications were necessary. 
Final Instrument
The final questionnaire consists of 72 items. Table 3 depicts 
the topics in the same order as they appear in the questionnaire.
The overall satisfaction with the healthcare system was 
operationalized using the question “All in all, how satisfied are 
you with your healthcare?”[1] with 5 answer categories ranging 
from “very satisfied” to “very unsatisfied.”
The perceived health system responsiveness is the main 
dependent variable in the planned analyses. It is measured by 
49 items in the questionnaire. The questions used in the short 
version MCSS questionnaire cover seven[2] WHO domains of 
health system responsiveness. We used the original wording 
of the German version whenever possible and only made 
slight changes if necessary [3]. Based on the results of the focus 
groups and the pretest, we included ten additional items, both 
for the domains developed by the WHO as well as for the 
two additional domains (trust and coordination). All items 
were included twice: once to assess the responsiveness of the 
healthcare provided by the GP and once for specialist care. All 
included items had 5 answer categories ranging from “very 
good” to “very bad.”
As a part of health system responsiveness, study participants 
were asked if they had experienced any kind of discrimination 
related to their healthcare within the last twelve months. In 
two following questions, participants could further specify in 
which aspect of their healthcare they perceived discrimination 
(eg, waiting times) and for which reason they thought they 
were disadvantaged (eg, no PHI). 
Additionally, we assessed the level of unmet healthcare need 
by asking participants if they experienced any situation 
within the last twelve months in which they perceived a need 
for healthcare but did not seek healthcare. In two following 
questions, participants could further specify for which kind of 
healthcare (eg, specialist’s consultation) and for which reason 
(eg, waiting times) they did not seek healthcare. 
Like all questions asking for subjective ratings, the questions 
on health system responsiveness might be influenced by 
differences in answer behaviour among different population 
groups. One approach to control for these differences is 
the usage of anchoring vignettes.14,15 We thus included one 
anchoring vignette per domain (for logistical reasons it was 
not possible to include multiple vignettes per domain, which 
is the more preferable approach in the usage of anchoring 
vignettes).
We included the EQ-5D 5L to assess health-related quality of 
life,16 as we assumed an association between perceived well-
being and perceived health system responsiveness. The EQ-
5D is one of the most frequently used questionnaires to assess 
health-related quality of life and has been tested extensively 
Table 1. Inclusion and Exclusion Criteria
Inclusion Exclusion
For All Groups
• 18 to 90 years at date of initial sample selection (23.9.2013)
• Continuously insured at the TK (from 1.1.2012-23.10.2013)
• The insured with increased data security regulation (eg, former 
employees of TK)
• The insured who are unable to participate in a written survey 
(eg, person with legal representative)
• Further TK standards (eg, insured person was contacted for a 
different survey within last 12 months by TK)
DMP Participants
• Continuous enrollment in indication specific DMP (from 1.1.2012-23.10.2013)
Non-DMP Participants
Minimum requirement for identification of type 2 diabetes patients based on claims 
data:
• One selected ICD-codea from hospital care within last 36 months
OR
• One selected ICD-code from ambulatory care AND one selected ATC-code within 
last 12 months
OR
• One selected ATC-code in at least 2 quarters within last 12 months
• Enrolment in any other DMP (1.1.2012-23.10.2013)
Minimum requirement for identification of CHD patients based on claims data:
• One selected ICD-code from hospital care within last 36 months
OR
• One selected ICD-code from ambulatory care AND one of the selected ATC-codes 
(level 1 or level 2) within last 12 months
OR
• One selected ATC-code (level 1) within last 12 months
• Enrolment in any other DMP (1.1.2012-23.10.2013)
Abbreviations: DMP, disease management programme; CHD, coronary heart disease; ATC, anatomical therapeutic chemical; ICD, International Classification 
of Diseases.
a See Table 2 for specific ICD and ATC codes.
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regarding validity and reliability.17,18 
As differences between participants and nonparticipants 
of DMPs are one focus of the project, we asked study 
participants if they take part in a DMP and in which of the 6 
currently available DMPs they participate in. Information on 
enrolment in a DMP will also be available from claims data 
(see SHI Administrative Claims Data section). Hence, in the 
upcoming analysis, a differentiation between four groups of 
study participants will be possible: (a) the person is enrolled 
in a DMP and knows about the enrolment, (b) the person is 
enrolled in a DMP but does not know about the enrolment, 
(c) the person is not enrolled in a DMP but believes to be 
enrolled, (d) the person is not enrolled in a DMP and knows 
that he/she is not enrolled. In addition, to analyse patient 
experiences with DMPs, we included six questions on DMP-
related patient education courses and documentation/
coordination within the DMP. 
In addition, to questions related to ‘objective’ socioeconomic 
characteristics (gender, age, highest educational achievement, 
number of persons within household – in total and under 
18 years –, monthly net-income), one item to assess the 
subjective socioeconomic status (subSES) was included. The 
subSES has been shown to correlate with health status.19 We 
thus hypothesized that it may also influence the perceived 
health system responsiveness. We operationalized subSES 
with the item “Today there is a lot of discussion about 
Table 2. ICD and ATC Codes Used for Sample Identification
Type 2 Diabetes 
ICD codes E11-E14
ATC codes
A10AB01-A10AB05, A10AB30, A10AC01-A10AC04, A10AC30, A10AD01-A10AD05, A10AD30, A10AE01- 
A10AE04, A10AE30, A10BA01-A10BA03, A10BB01-A10BB12, A10BB31, A10BC01, A10BD01-A10BD03, 
A10BF01-A10BF03, A10BG01-A10BG03, A10BH01, A10BP01, A10BP02, A10BP30, A10BX01-A10BX04, 
A10XA01
CHD
ICD codes I20-I25, I50
ATC-codes level 1 C01DA02, C01DA05, C01DA08, C01DA14, C01DA52, C01DX11, C01DX12
ATC codes level 2
C07AA03, C07AA05, C07AA07, C07AB02, C07AB03, C07AB05, C07AB07, C07AB08, C07AB12, C07AB13, 
C07AG02, C09AA01-C09AA11, C09BA01-C09BA09, C09BB05, C09BB10
Abbreviations: ATC, anatomical therapeutic chemical; ICD, International Classification of Diseases; CHD, coronary heart disease.
Table 3. Topics Covered by Questionnaire
Topic No. of Items
Overall satisfaction with healthcare system 1
Health system responsiveness
Rated experiences with GP (related to last visit within 
last 12 months) 
17
Rated experiences with specialist care (related to last 
visit within last 12 months) 
17
Perceived discrimination within last 12 months 3
Perceived unmet need for healthcare within last 12 
months
3
Anchoring vignettes 9
Health related quality of life (EQ-5D 5L) 6
Questions on DMP 7
Sociodemographic characteristics 7
Subjective socioeconomic status 1
Assistance with completing the questionnaire 1
Abbreviations: DMP, disease management programme; GP, general 
practitioner.
different social classes. In your opinion, which social class do 
you belong to?”[4]. The item was used previously in various 
surveys in Germany.20 However, based on the results from the 
qualitative pretest, we modified the answer categories slightly 
by changing ‘working class’ into ‘lower middle class,’ which 
led to the following six answer categories: ‘lower class,’ ‘lower 
middle class,’ ‘middle class,’ ‘upper middle class,’ ‘upper class,’ 
and ‘none of these.’
Since we expected our target group to be less healthy and 
older than the general population, we assumed that some of 
the surveyed persons might need help with completing the 
questionnaire. Hence, we asked all participants if they have 
had any assistance with filling in the questionnaire, to use this 
information as a control variable in the planned data analyses. 
Statutory Health Insurance Administrative Claims Data
Sickness funds routinely collect SHI claims data, which 
serves as a second data source for the purpose of this study. 
A German sickness fund – the TK – with 8.9 million insured 
people in 2014 provides claims data for this study. The data is 
used to derive information on morbidity, service utilization, 
and sociodemographic characteristics. Table 4 shows the topic 
related variables provided by SHI administrative claims data.
Complementary to the subjective well-being assessed within 
the postal survey, information on disease severity as well as 
on further comorbidities is generated using claims data. For 
both substudies, type 2 diabetes and CHD, we selected disease 
specific ICD- (International Classification of Diseases), OPS- 
(Operationen- und Prozedurenschlüssel – German procedure 
coding) and ATC-codes (Anatomical Therapeutic Chemical 
classification system), which represent differing levels of 
disease severity or frequent comorbidities. Additionally, 
as a generic comorbidity measure, we apply the Charlson 
comorbidity index for ambulatory care.21,22 
It is hypothesized that the structure of care delivery, which 
is operationalized by the status of DMP enrolment as well 
as the status of enrolment in an integrated care model (eg, 
family physician care model), determines the perceived 
health system responsiveness. Likewise, service utilization is 
one explanatory variable for the perception of health system 
responsiveness. It is operationalized for inpatient care by the 
number and length of hospital stays and for ambulatory care 
by the number of days with service accounting of GPs and 
specialists, both deduced from the claims data.
In Germany, fee-for-service is the regular payment system for 
GPs and specialists in ambulatory care. However, in 2009 a 
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quarterly capitation type lump sum has been introduced (paid 
if a patient has at least one contact) which includes several 
usually provided services (eg, medical care, coordination, 
documentation). Thus, the exact number of contacts with 
GPs and specialists cannot-be derived from claims data, and 
we use the number of days with service accounting as a proxy. 
This may lead to an underestimation of actual contacts, since 
some of these do not lead to separate accounting, but fall 
under the lump sum. 
Healthcare service provision can be assumed to vary strongly 
between urban and rural living areas; perceived health system 
responsiveness may vary accordingly. Due to data protection 
regulations, the inclusion of the postal or district code in the 
final dataset was impossible. Yet, it was possible to transfer the 
district codes into 4 and 9 categories, respectively, that describe 
the level of urbanization according to the categorization 
system of the German Federal Institute for Research on 
Building, Urban Affairs and Spatial Development. To allow 
for sensitivity analysis, we transferred the codes to both 
systems. Additionally, information on the federal state of the 
residential area is available.
Sample and Data Linkage
For all selected participants, a pseudonym was used. 
Participants received the described questionnaire and a 
letter of informed consent (both with their pseudonym) 
as well as information on data protection. In the letter of 
informed consent, participants agreed to the linkage of 
selected individual-level SHI administrative claims data 
with their respective survey data. Only data of participants 
who completed the questionnaire and signed the informed 
consent will be included in further analyses (see Figure). 
Via the pseudonyms, the survey data will be linked with the 
claims data at individual-level. Pseudonyms will be deleted 
after the linkage to generate anonymous data.
While the questionnaire was mailed at the end of October 
2013, it included several questions relating to the last 12 
months (eg, the questions on health system responsiveness). 
The SHI administrative claims data cover 6 quarters, from 
April 2012 through September 2013, and hence overlap with 
the retrospective survey data.
Data Cleaning and Planned Analysis 
All analyses will be conducted on a cleaned dataset with cases 
that fulfil the following minimum requirements regarding 
data quality. As all planned analyses need information from 
both data sources, only the cases with linked questionnaire 
and claims data will be included. Questionnaire data will 
be excluded if parts from the questionnaire (eg, whole 
pages, or cut-outs from pages) are missing. In addition, 
if more than 50% of the questionnaire pages are not 
completed, or if systematically the front- or the backside 
from the questionnaire is not filled-in, cases will also be 
excluded. As all planned analyses will include information 
on the sociodemographic characteristics provided in the 
questionnaire, cases without any of this information will also 
be excluded. 
The planned data analyses incorporate various strategies: these 
include descriptive analyses, multivariate analyses as well as 
the modelling of heterogeneous reporting behaviour based on 
answers to anchoring vignettes. Special attention will be paid 
to the comparison of different groups, eg, DMP-participants 
and nonparticipants and suitable methods will be applied 
to account for group differences. Differences in reporting 
behaviour regarding the health system responsiveness-
items will be analysed by means of the included anchoring 
vignettes.4
Preliminary Results and Feasibility
A total sample of 51 998 persons was contacted. Of these, 
17 213 (33.10%) sent back the questionnaire and 16 672 
(32.06%) sent back the informed consent, which makes a 
gross response rate of 33.29% (17 311 individual cases). Of 
16 573 (31.87%) linked cases, 1008 cases were excluded due 
to inadequate completed questionnaire and after plausibility 
check. The final response of valid cases is n = 15 565 (29.93%). 
Table 5 shows the results from the (non)responder analysis.
In all categories, patients with diabetes show a lower response 
rate than patients with CHD. In both subgroups men and 
patients enrolled in a DMP have a higher response rate than 
women and patients not enrolled in a DMP, respectively. 
Furthermore, the response rate increases with age but 
decreases in the age group of >80 years. The response rate 
across the federal states ranges between 40.99% in Saxony 
Table 4. Variables Derived From SHI Administrative Claims Data
Topic Variable Indicator
(Co)Morbidity Level of long-term care entitlement
Complications and comorbidities according to the 
Charlson-comorbidity index and related to type 2 
diabetes and CHD 
Level 1/2/3
Selected ICD-10 codes in ambulatory and hospital care, ATC codes, OPS codes
Care delivery Enrolment in DMP
Enrolment in Integrated Care Model
Enrolment in selected DMP and/or other DMP
Enrolment in Integrated Care Model
Service utilization Number of hospital stays
Length of hospital stay
Contacts with ambulatory healthcare provider
Number of admissions within one quarter
Total length of stay in days within one quarter
Number of days with service accounting separated by GP and specialist 
within one quarter
Sociodemographics Age
Gender
Living area
In years
Male/female
Federal state, 4 and 9 categories of urbanization 
Abbreviations: SHI, statutory health insurance; DMP, disease management programme; GP, general practitioner; CHD, coronary heart disease; ATC, 
anatomical therapeutic chemical; ICD, International Classification of Diseases; OPS, Operationen- und Prozedurenschlüssel.
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and 25.90% in Mecklenburg-West Pomerania (CHD) and 
between 34.84% in Saxony and 21.43% in Mecklenburg-West 
Pomerania (Diabetes).
Data Protection
Since this study includes a survey of statutory health insured, 
who were contacted by their sickness fund, certificate of 
nonobjection for the study was obtained by the German 
Federal (Social) Insurance Authority.
The project partners, in accordance with the respective data 
security engineers, have developed strict criteria (included 
in the project proposal) regarding the sampling of patients, 
the mailing of the questionnaire, and the storage, linkage and 
access of the data to secure the privacy and confidentiality of 
Figure. Linkage of Survey and statutory health insurance (SHI) 
Administrative Claims Data.
Table 5. Sample Response
CHD Diabetes type 2
Original Sample (n) Finally Linked (n) Response Rate (%) Original Sample (n) Finally Linked (n) Response Rate (%)
Gender
Female 7959 2131 26.77 9691 2326 24.00
Male 18 040 6345 35.17 16 308 4763 29.21
Age
≤60 years 6245 1292 20.69 8521 1485 17.43
61–65 years 3185 902 28.32 3852 1044 27.10
66–70 years 3546 1216 34.29 3831 1182 30.85
71–75 years 5547 2220 40.02 4690 1645 35.07
76–80 years 4280 1763 41.19 3246 1186 36.54
>80 years 3196 1083 33.89 1859 547 29.42
DMP enrolment
Yes 13 000 5141 39.55 13 000 4228 32.52
No 12 999 3335 25.66 12 999 2861 22.01
Region
West-Germany 20 534 6608 32.18 20 154 5399 26.79
East-Germany 5465 1867 34.16 5845 1690 28.91
Total 25 999 8476 32.60 25 999 7089 27.27
Abbreviations: DMP, disease management programme; CHD, coronary heart disease.
the data at all times during the project.
Discussion
To our knowledge, this is the first study linking survey data 
to health system responsiveness at individual level with 
SHI administrative claims data, comprising information 
on medical diagnoses, prescriptions of pharmaceuticals, 
healthcare service utilization and sociodemographic 
characteristics. 
With this unique database, we will be able to comprehensively 
analyse determinants of health system responsiveness and 
its relation to other aspects of health system performance 
assessment, such as health outcomes and equity. Yet, it has to 
be considered that, due to the nature of the data (only from 
one sickness fund, only specific diseases), the results from the 
project will not be necessarily generalizable for the German 
healthcare system as a whole. Nevertheless, the project will 
lead to new insights on the determinants of health system 
responsiveness, eg, with regard to service utilisation and (co)
morbidities. In addition, it will allow German health system 
stewards to assess the performance of nonclinical aspects of 
healthcare delivery and their determinants in two important 
areas of health policy: in outpatient and chronic disease care.
The usage and linkage of different data sources is of high 
potential for assessing health system performance not only 
in Germany but internationally. Yet, there are still various 
aspects in health system performance assessment where the 
combination of various datasets has hardly been explored or 
actually applied. In this study protocol we demonstrate one 
potential approach for using different data sources in health 
system performance assessment. We use SHI administrative 
claims data for the sample selection and link them eventually 
to survey data, which imposes a particular challenge to the 
conceptualization of data protection requirements as well as 
the sample selection. Even though the approach was related to 
a rather high effort for the survey participants (completion of 
the questionnaire and signing the informed consent form) the 
preliminary results with a net-response rate of 29.93% indicate 
 
Study 
participants 
Response: Questionnaire and 
consent form with pseudonym 
Trust center 
Signed consent form with 
pseudonym 
TK 
TU Berlin Questionnaire with pseudonym 
For cases with signed consent form: 
select SHI administrative data via 
pseudonym  
 Identification of sample and 
generation of pseudonyms 
 Preparation and mailing of 
questionnaires and consent form 
with pseudonym 
TK 
 Entry of questionnaire 
data 
 Linkage of SHI 
accounting data and 
questionnaire data via 
pseudonym 
 Deletion of 
psyeudonyms 
 all further analyses 
with anonymised 
dataset 
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a good acceptance of the approach by the survey participants. 
Thus, this approach should be of interest for health system 
performance assessment in general.
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Endnotes
[1] Please note that the original questionnaire is in German. 
[2] We excluded the domain “social support” as it is only used for inpatient care.
[3] That is: we made changes to the “prompt attention” item, as we differentiate 
between the waiting time in the waiting room and the waiting time from asking 
for an appointment until the appointment; we made slight changes in the 
“autonomy” item by replacing “the treatment” with “your treatment.”
[4] Authors’ own translation, original wording in German.
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